glp-1 manufacturing process Development of drug alone and carrier-based dry powder inhaler formulations GLP1 Therapies​

Heppner FL, Ransohoff RM, Becher B

Disclaimer: Este producto no est destinado a diagnosticar, tratar, curar o prevenir ninguna enfermedad

These agents include semaglutide (Ozempic, Wegovy), liraglutide (Victoza, Saxenda), dulaglutide (Trulicity), and tirzepatide (Mounjaro, Zepbound), which also targets the glucose-dependent insulinotropic polypeptide (GIP) receptor

SAGE Open Medical Case Reports

Rodrguez-Santana C, Florido J, Martnez-Ruiz L, Lpez-Rodrguez A, Acua-Castroviejo D, Escames G

The patients preference, comfort and ease with technology, willingness to engage with the device, caregiver support, interacting medications, and insurance coverage, along with device affordability, are important factors in determining which CGM is appropriate